The FDA is providing an update on the agency’s efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic. Read more...
Enlivex Therapeutics announced an investigator-initiated multi-center Phase II clinical trial of Allocetra in COVID-19 patients has commenced. Read more...
Trxade Group announced its wholly-owned subsidiary, Integra Pharma Solutions, has formally withdrawn its EUA application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to FDA guidance. Read more...
OPTI Medical Systems announced the FDA has granted EUA for the OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. Read more...